Literature DB >> 6733003

Interaction between warfarin and propranolol.

A K Scott, B K Park, A M Breckenridge.   

Abstract

The interaction between propranolol and warfarin was investigated in six healthy volunteers using a low dose warfarin protocol and in New Zealand white rabbits. Warfarin concentration (Cmin) in the volunteers increased by 14.7% on addition of propranolol (P less than 0.02). There was no significant change in prothrombin time. In the rabbit study, elimination half-life was shorter in the propranolol treated animals (8.20 +/- 0.44 h) than in controls (10.89 +/- 0.62 h). This was due to a fall in its volume of distribution from 1.13 +/- 0.10 1 kg-1 in controls to 0.81 +/- 0.08 1 kg-1 in the propranolol treated group. Clearance was not significantly altered. The small change in warfarin concentration could be of clinical importance in some patients because warfarin has a low therapeutic index. This requires further investigation.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6733003      PMCID: PMC1463461          DOI: 10.1111/j.1365-2125.1984.tb02390.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  14 in total

1.  A study of the effect of anticoagulants on [3H]vitamin K1 metabolism and prothrombin complex activity in the rabbit.

Authors:  B K Park; J B Leck; A C Wilson; M J Serlin; A M Breckenridge
Journal:  Biochem Pharmacol       Date:  1979-04-15       Impact factor: 5.858

2.  High-performance liquid chromatographic separation and fluorescence detection of warfarin and its metabolites by postcolumn acid/base manipulation.

Authors:  S H Lee; L R Field; W N Howald; W F Trager
Journal:  Anal Chem       Date:  1981-03       Impact factor: 6.986

3.  Effects of metoprolol and propranolol on theophylline elimination.

Authors:  K A Conrad; D W Nyman
Journal:  Clin Pharmacol Ther       Date:  1980-10       Impact factor: 6.875

4.  Warfarin. Stereochemical aspects of its metabolism and the interaction with phenylbutazone.

Authors:  R J Lewis; W F Trager; K K Chan; A Breckenridge; M Orme; M Roland; W Schary
Journal:  J Clin Invest       Date:  1974-06       Impact factor: 14.808

5.  Lack of effect of ranitidine on warfarin action.

Authors:  M J Serlin; R G Sibeon; A M Breckenridge
Journal:  Br J Clin Pharmacol       Date:  1981-12       Impact factor: 4.335

6.  Inhibition of antipyrine metabolism by beta-adrenoceptor antagonists.

Authors:  N D Bax; M S Lennard; G T Tucker
Journal:  Br J Clin Pharmacol       Date:  1981-12       Impact factor: 4.335

7.  Interaction between diflunisal and warfarin.

Authors:  M J Serlin; S Mossman; R G Sibeon; K F Tempero; A M Breckenridge
Journal:  Clin Pharmacol Ther       Date:  1980-10       Impact factor: 6.875

8.  Warfarin metabolism in man: identification of metabolites in urine.

Authors:  R J Lewis; W F Trager
Journal:  J Clin Invest       Date:  1970-05       Impact factor: 14.808

9.  Cimetidine: interaction with oral anticoagulants in man.

Authors:  M J Serlin; R G Sibeon; S Mossman; A M Breckenridge; J R Williams; J L Atwood; J M Willoughby
Journal:  Lancet       Date:  1979-08-18       Impact factor: 79.321

10.  Impairment of antipyrine clearance in humans by propranolol.

Authors:  D J Greenblatt; K Franke; D H Huffman
Journal:  Circulation       Date:  1978-06       Impact factor: 29.690

View more
  4 in total

1.  Drug interactions and beta blockers.

Authors:  L Beeley
Journal:  Br Med J (Clin Res Ed)       Date:  1984-11-17

2.  The effect of beta-adrenoceptor antagonists on the pharmacokinetics and pharmacodynamics of warfarin after a single dose.

Authors:  N D Bax; M S Lennard; G T Tucker; H F Woods; N R Porter; R G Malia; F E Preston
Journal:  Br J Clin Pharmacol       Date:  1984-05       Impact factor: 4.335

3.  Lack of an interaction between propranolol and sumatriptan.

Authors:  A K Scott; T Walley; A M Breckenridge; L F Lacey; P A Fowler
Journal:  Br J Clin Pharmacol       Date:  1991-11       Impact factor: 4.335

Review 4.  Clinically important drug interactions with anticoagulants. An update.

Authors:  S Harder; P Thürmann
Journal:  Clin Pharmacokinet       Date:  1996-06       Impact factor: 6.447

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.